ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 243 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $4,397,000 | +28.5% | 47,315 | -17.7% | 0.01% | +18.2% |
Q3 2021 | $3,423,000 | +23.0% | 57,485 | +40.8% | 0.01% | +22.2% |
Q2 2021 | $2,784,000 | +3.8% | 40,817 | +5.6% | 0.01% | 0.0% |
Q1 2021 | $2,683,000 | -12.7% | 38,660 | -3.4% | 0.01% | -18.2% |
Q4 2020 | $3,075,000 | -3.0% | 40,017 | -5.6% | 0.01% | -15.4% |
Q3 2020 | $3,169,000 | +25.3% | 42,369 | +5.5% | 0.01% | +18.2% |
Q2 2020 | $2,529,000 | +26.8% | 40,175 | -15.4% | 0.01% | +10.0% |
Q1 2020 | $1,994,000 | -7.6% | 47,481 | 0.0% | 0.01% | +25.0% |
Q4 2019 | $2,157,000 | +7.4% | 47,481 | +8.2% | 0.01% | 0.0% |
Q3 2019 | $2,009,000 | – | 43,900 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 164,300 | $9,633,000 | 4.86% |
Atika Capital Management LLC | 230,000 | $13,485,000 | 2.65% |
DAFNA Capital Management LLC | 93,942 | $5,508,000 | 2.07% |
PFM Health Sciences, LP | 1,828,378 | $107,198,000 | 2.04% |
Perceptive Advisors | 1,380,171 | $80,919,000 | 1.86% |
Eversept Partners, LP | 73,501 | $4,309,364 | 1.21% |
Partner Investment Management, L.P. | 18,159 | $1,065,000 | 1.13% |
Rhenman & Partners Asset Management AB | 170,000 | $9,967,000 | 1.10% |
EMERALD ADVISERS, LLC | 425,510 | $24,948,000 | 1.00% |
EMERALD MUTUAL FUND ADVISERS TRUST | 388,418 | $22,773,000 | 0.90% |